2nd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for WALGREEN CO.
Client
Income
$80,000
Expenses
—
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmacist provider status Drug pricing Pharmacy benefits on military bases H.R. 748 CARES Act - Issues related to COVID-19 relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| BRIAN MCKEON | — |
| JEROME MURRAY | — |
| BRIAN WILD | — |
| ARI ZIMMERMAN | — |
Taxation/Internal Revenue Code TAX
Implementation of H.R. 1 (Tax Cuts and Jobs Act of 2017)
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAROLD HANCOCK | — |
| RUSSELL W. SULLIVAN | — |
| BRIAN WILD | — |
Health Issues HCR
Immunization program COVID-19 testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| R. JAMES NICHOLSON New | Secretary Dept of Veterans Affairs; Ambassador to Holy See Dept of State |
| BRIAN WILD | — |
| ARI ZIMMERMAN | — |
Foreign Relations FOR
Foreign relations issues; market access
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS MAGUIRE | — |
Medicare/Medicaid MMM
DIR Reform Rebate Rule Drug Pricing H.R. 748 CARES Act - Issues related to COVID-19 relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| JEROME MURRAY | — |
| BRIAN WILD | — |
Medical/Disease Research/Clinical Labs MED
DIR reform; drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.